advertisement

WGA Rescources

11.4 Prostaglandins (15)

Showing records 1 to 15

Display all abstracts in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins
54657 Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice
Wang G; Xu X; Yao X; Zhu Z; Yu L; Chen L; Chen J; Shen X
Diabetologia 2013; 56: 2702-2712
54480 Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
Inoue K; Tanaka A; Tomita G
Clinical Ophthalmology 2013; 7: 1411-1416
54506 Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics
Woodward DF; Wang JW; Poloso NJ
Pharmacological Reviews 2013; 65: 1135-1147
54414 Cytomegalovirus anterior uveitis in immunocompetent individuals following topical prostaglandin analogues
Babu K; Murthy GJ
Journal of Ophthalmic Inflammation and Infection 2013; 3: 55
54564 Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
Shafiee A; Bowman LM; Hou E; Hosseini K
Clinical Ophthalmology 2013; 7: 1549-1556
54779 A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure
Nixon DR
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 876-881
54493 Incidence of deepening of upper eyelid sulcus after topical use of tafluprost ophthalmic solution in Japanese patients
Maruyama K; Tsuchisaka A; Sakamoto J; Shirato S; Goto H
Clinical Ophthalmology 2013; 7: 1441-1446
54427 Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost
Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
Clinical and Experimental Ophthalmology 2014; 42: 126-131
54743 Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study
Tam AL; Gupta N; Zhang Z; Yü,cel YH
Translational vision science & technology 2013; 2: 3
54488 Relative Efficacy and Safety of Preservative-free Latanoprost (T2345) for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: An Adjusted Indirect Comparison Meta-Analysis of Randomized Clinical Trials
Cucherat M; Stalmans I; Rouland JF
Journal of Glaucoma 2014; 23: e69-e75
54643 Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits
Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 817-820
54573 Effect of preservative-free tafluprost on keratocytes, sub-Basal nerves, and endothelium: a single-blind one-year confocal study on naïve or treated glaucoma and hypertensive patients versus a control group
Rossi GC; Blini M; Scudeller L; Ricciardelli G; Depolo L; Amisano A; Bossolesi L; Pasinetti GM; Bianchi PE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 821-825
54624 Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma
Tomić M; Ka&scaron,telan S; Soldo KM; Salopek-Rabatić J
BioMed research international 2013; 2013: 603782
54466 Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma
Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S
Investigative Ophthalmology and Visual Science 2013; 54: 5629-5637
54738 Efficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma
Kocabora MS; Ozsutcu M; Kandemir N; Gocmez E; Fazil K; Gulkilik G
Clinica Terapeutica 2013; 164: e259-e262

Issue 15-3

Change Issue


advertisement

Oculus